Catalyst Wire Dossier Catalyst Wire Dossier

i-SENS Self-Monitoring Blood Glucose / β-Ketone System

· i-SENS, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for i-SENS Self-Monitoring Blood Glucose / β-Ketone System, covering 2024-02-29 to 2024-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System [NA]

See pricing